Cited by 648BRCA gene mutations in cancerDNA Repair MechanismsPARP inhibition in cancer therapy

The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Welcsh, P. L.·2001·Human Molecular Genetics

Open this paper in CoChat — free account

Abstract

Germline mutations in the tumor suppressor genes BRCA1 and BRCA2 predispose individuals to breast and ovarian cancers. Progress in determining the function of BRCA1 and BRCA2 suggests that they are involved in two fundamental cellular processes: DNA damage repair and transcriptional regulation. We evaluate current knowledge of BRCA1 and BRCA2 functions to explain why mutations in BRCA1 and BRCA2 lead specifically to breast and ovarian cancer. The BRCA1 and BRCA2 genes contain unusually high densities of repetitive elements. These features of the BRCAs genomic regions contribute to chromosomal instability of these genes. We propose that somatic alterations of BRCA1 and BRCA2 are common and driven by rearrangements between repetitive elements. Inherited and somatic mutations occur in BRCA1 and BRCA2; virtually all somatic mutations are the result of large genomic rearrangements. What are the consequences of such large somatic mutations of BRCA1 and BRCA2 in women with or without inherited mutations? The breast and ovary are estrogen-responsive tissues. Beginning in puberty, the breast epithelium proliferates rapidly in response to fluctuating levels of estrogen. We present a genetic model outlining how BRCA-deficient cells may gain uncontrolled proliferation leading to tumor formation. Central to this model of BRCA-mediated tumorigenesis are estrogen-mediated proliferation of breast and ovarian epithelium and the distinctive genomic context of the BRCA genes.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1093/hmg/10.7.705

Cites

92 of 92 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J. J., Shattuck-Eidens, D. M., Futreal, P. A., Harshman, K., Tavtigian, S. V., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,069
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G. R., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S. G., Gumbs, C. E., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage
Paull, T. T., Rogakou, E. P., Yamazaki, V., Kirchgessner, C. U., Gellert, M., & Bonner, W. M. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00610-2 · Cited by 2,098
Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13
Wooster, R., Neuhausen, S. L., Mangion, J., Quirk, Y., Ford, D., Collins, N., Nguyen, K. N., Seal, S., Tran, T. D., Averill, D., et al. (1994) · Science · doi:10.1126/science.8091231 · Cited by 1,918
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Association of BRCA1 with Rad51 in Mitotic and Meiotic Cells
Scully, R., Chen, J., Plug, A., Xiao, Y., Weaver, D., Feunteun, J., Ashley, T., & Livingston, D. M. (1997) · Cell · doi:10.1016/s0092-8674(00)81847-4 · Cited by 1,459
Cancer risks in BRCA2 mutation carriers.
Olsson, H. (1999) · Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1310 · Cited by 1,404
BRCA1 mutations in primary breast and ovarian carcinomas.
Futreal, P., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L., Haugen-Strano, A., Swensen, J., & Miki, Y. (1994) · Science · doi:10.1126/science.7939630 · Cited by 1,378
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
Wang, Y., Cortez, D., Yazdi, P., Neff, N., Elledge, S. J., & Qin, J. (2000) · Genes & Development · doi:10.1101/gad.14.8.927 · Cited by 1,221

Show all 93 references

Sorted by citations

Items 201–300 of 647

Expression and mutations of BRCA in breast cancer and ovarian cancer: Evidence from bioinformatics analyses
Wang, Z., Zhang, J., Zhang, Y., Deng, Q., & Liang, H. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3870 · Cited by 40
Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5′ end of the BRCA1 gene
Claes, K., Vandesompele, J., Poppe, B. G., Dahan, K., Coene, I., Paepe, A. D., & Messiaen, L. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205520 · Cited by 40
Risk of Primary Non–Breast Cancer After Female Breast Cancer by Age at Diagnosis
Mellemkjær, L., Christensen, J., Frederiksen, K., Pukkala, ., Weiderpass, E., Bray, F., Friis, S., Andersson, M., & Olsen, J. H. (2011) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0009 · Cited by 39
Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib
Pathade, A. D., Kommineni, N., Bulbake, U., Thummar, M. M., Samanthula, G., & Khan, W. (2019) · AAPS PharmSciTech · doi:10.1208/s12249-019-1468-y · Cited by 40
BRCA1a has antitumor activity in TN breast, ovarian and prostate cancers
Yuli, C., Shao, N., Rao, R., Aysola, P., Reddy, V., Oprea-llies, G., Lee, L., Okoli, J., Partridge, E. E., Reddy, E. S. P., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210420 · Cited by 39
A novel protein‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patients
Martínez‐Terroba, E., Behrens, C., de Miguel, F. J., Agorreta, J., Monsó, E., Millares, L., Sainz, C., Mesa, M., Perez‐Gracia, J. L., Lozano, M. D., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5096 · Cited by 38
Emerging therapeutic modalities of PARP inhibitors in breast cancer
Wang, X., Shi, Y., Huang, D., & Guan, X. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.05.014 · Cited by 38
Ethnic-specific BRCA1/2 variation within Asia population: evidence from over 78 000 cancer and 40 000 non-cancer cases of Indian, Chinese, Korean and Japanese populations
Bhaskaran, S. P., Huang, T., Rajendran, B. K., Guo, M., Luo, J., Qin, Z., Zhao, B., Chian, J., Li, S., & Wang, S. M. (2020) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2020-107299 · Cited by 37
Brief Report: Towards a dietary prevention of hereditary breast cancer
Kotsopoulos, J., & Narod, S. A. (2005) · Cancer Causes & Control · doi:10.1007/s10552-004-2593-8 · Cited by 39
Risk of second primary cancer after breast cancer treatment
Marcu, L. G., Santos, A. M. C., & Bezak, E. (2013) · European Journal of Cancer Care · doi:10.1111/ecc.12109 · Cited by 37
A mitotic function for the high-mobility group protein HMG20b regulated by its interaction with the BRC repeats of the BRCA2 tumor suppressor
Lee, M., Daniels, M. J., Garnett, M. J., & Venkitaraman, A. R. (2011) · Oncogene · doi:10.1038/onc.2011.55 · Cited by 37
Of mice, cats, and men: Is human breast cancer a Zoonosis?
Szabo, S., Haislip, A. M., & Garry, R. F. (2005) · Microscopy Research and Technique · doi:10.1002/jemt.20232 · Cited by 37
Association of common ATMvariants with familial breast cancer in a South American population
González‐Hormazábal, P., Bravo, T., Blanco, R., Valenzuela, C. Y., Gómez, F., Waugh, E., Peralta, O., Ortuzar, W. I., Reyes, J. M., & Lilian Jara, S. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-117 · Cited by 37
P53 codon 72 polymorphism and BRCA 1 and 2 mutations in ovarian epithelial malignancies in black South Africans
Pegoraro, R. J., Moodley, M., Rom, L., Chetty, R., & Moodley, J. (2003) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2003.13333.x · Cited by 37
Evolution of Premalignant DiseasePreprint
Curtius, K., Wright, N. A., & Graham, T. A. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026542 · Cited by 38
Participation of proteasome-ubiquitin protein degradation in autophagy and the activation of AMP-activated protein kinase
Jiang, S., Park, D. W., Gao, Y., Ravi, S., Darley-Usmar, V. M., Abraham, E., & Zmijewski, J. W. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.024 · Cited by 41
Cardiovascular risk of BRCA1/2 mutation carriers: A review
van Westerop, L., Jong, M. A.-D., Hoogerbrugge, N., de Hullu, J. A., & Maas, A. H. E. M. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.06.012 · Cited by 36
DNA Methylation Profiles of Female Steroid Hormone-Driven Human Malignancies
Campan, M., Weisenberger, D. J., & Laird, P. W. (2006) · Springer eBooks · doi:10.1007/3-540-31181-5_8 · Cited by 37
Understanding Germ-Line Mutations inBRCA1
Szabo, C. I., Worley, T., & Monteiro, Á. N. A. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.6.841 · Cited by 37
Edge biomarkers for classification and prediction of phenotypes
Zeng, T., Zhang, W., Yu, X., Liu, X., Li, M., Liu, R., & Chen, L. (2014) · Science China Life Sciences · doi:10.1007/s11427-014-4757-4 · Cited by 36
Combining Low Temperature Fluorescence DNA-Hybridization, Immunostaining, and Super-Resolution Localization Microscopy for Nano-Structure Analysis of ALU Elements and Their Influence on Chromatin Structure
Krufczik, M., Sievers, A., Hausmann, A., Lee, J., Hildenbrand, G. L., Schaufler, W., & Hausmann, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18051005 · Cited by 35
DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
Mikheikin, A. L., Olsen, A., Leslie, K. A., Russell-Pavier, F. S., Yacoot, A., Picco, L., Payton, O., Toor, A. A., Chesney, A. E., Gimzewski, J. K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01891-9 · Cited by 35
Risk of Second Primary Female Genital Malignancies in Women with Breast Cancer: a SEER Analysis
Li, Z., Wu, Q., Song, J., Zhang, Y., Zhu, S., & Sun, S. (2018) · Hormones and Cancer · doi:10.1007/s12672-018-0330-0 · Cited by 35
Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?
Lavoro, A., Scalisi, A., Candido, S., Zanghì, G., Rizzo, R., Gattuso, G., Caruso, G., Libra, M., & Falzone, L. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5349 · Cited by 36
BRCA Mutations and Fertility Preservation
Nunes, J. D., Demeestere, I., & Devos, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010204 · Cited by 42
Potentiation of Temozolomide Cytotoxicity by Inhibition of DNA Polymerase β Is Accentuated by BRCA2 Mutation
Stachelek, G. C., Dalal, S., Donigan, K. A., Hegan, D. C., Sweasy, J. B., & Glazer, P. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1353 · Cited by 33
HZE Radiation Non-Targeted Effects on the Microenvironment That Mediate Mammary Carcinogenesis
Barcellos‐Hoff, M. H., & Mao, J. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00057 · Cited by 34
Novel aspects of macromolecular repair and relationship to human disease
Krokan, H. E., Kavli, B., & Slupphaug, G. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0528-1 · Cited by 36
Down-Regulation of BRCA1 in Chronic Pancreatitis and Sporadic Pancreatic Adenocarcinoma
Beger, C., Ramadani, M., Meyer, S., Leder, G. H., Krüger, M., Welte, K., Gansauge, F., & Beger, H. G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0992-3 · Cited by 34
Targeted Nanopore Sequencing with Cas9 for studies of methylation, structural variants, and mutationsPreprint
Gilpatrick, T., Lee, I., Graham, J. E., Raimondeau, E., Bowen, R., Heron, A., Sedlazeck, F. J., & Timp, W. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/604173 · Cited by 34
Mitochondrial DNA variants and risk of familial breast cancer: An exploratory study
Tommasi, S., FAVIA, P., Weigl, S., Bianco, A., Pilato, B., Russo, L., Paradiso, A., & Petruzzella, V. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2324 · Cited by 33
Estrogen‐induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER‐positive breast cancer cells
Guo, P., Dong, X., Zhao, K., Sun, X., Li, Q., & Dong, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.24696 · Cited by 33
BRCA1/2 mutation carriers are potentially at higher cardiovascular risk
Jong, M. A.-D., Maas, A. H. E. M., Massuger, L. F. A. G., Hoogerbrugge, N., & de Hullu, J. A. (2014) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2014.01.008 · Cited by 33
Regulation of BRCA1 phosphorylation by interaction with protein phosphatase 1alpha.
Liu, Y., Virshup, D. M., White, R. L., & Hsu, L. (2002) · PubMed · Cited by 33
GermlineBRCA1 promoter deletions in UK and Australian familial breast cancer patients: Identification of a novel deletion consistent withBRCA1:?BRCA1 recombination
Brown, M. A., Lo, L.-J., Catteau, A. L., Xu, C., Lindeman, G. J., Hodgson, S. V., & Solomon, E. (2002) · Human Mutation · doi:10.1002/humu.10055 · Cited by 34
Therapeutic potential of stem cells expressing suicide genes that selectively target human breast cancer cells: Evidence that they exert tumoricidal effects via tumor tropism
YI, B.-R., CHOI, K. J., KIM, S. U., & CHOI, K.-C. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1523 · Cited by 32
Microtubule-Associated Protein Mdp3 Promotes Breast Cancer Growth and Metastasis
Tala, Xie, S., Sun, X., Sun, X., Ran, J., Zhang, L., Li, D., Liu, M., Bao, G., & Zhou, J. (2014) · Theranostics · doi:10.7150/thno.9727 · Cited by 32
Germline BRCA1 mutation reprograms breast epithelial cell metabolism towards mitochondrial-dependent biosynthesis: evidence for metformin-based “starvation” strategies in BRCA1 carriers
Cuyàs, E., Fernández‐Arroyo, S., Alarcón, T., Lupu, R., Joven, J., & Menéndez, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.9732 · Cited by 32
Methylation of BRCA1 and MGMT genes in white blood cells are transmitted from mothers to daughters
Al‐Moghrabi, N., Al‐Showimi, M., Al‐Yousef, N., Alshahrani, B., Karakas, B., Alghofaili, L., Almubarak, H. F., Madkhali, S., & Humaidan, H. A. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0529-5 · Cited by 32
BRCA1 variants in a family study of African-American and Latina women
McKean‐Cowdin, R., Feigelson, H. S., Xia, L. Y., Pearce, C. L., Thomas, D. C., Stram, D. O., & Henderson, B. E. (2005) · Human Genetics · doi:10.1007/s00439-004-1240-5 · Cited by 32
Mitochondrial genotype and breast cancer predisposition
Petros (2010) · Oncology Reports · doi:10.3892/or_00001014 · Cited by 32
Quartz crystal microbalance genosensor for sequence specific detection of attomolar DNA targets
Rasheed, P. A., & Sandhyarani, N. (2015) · Analytica Chimica Acta · doi:10.1016/j.aca.2015.11.033 · Cited by 32
Androgen receptor expression in breast cancer patients tested for BRCA1 and BRCA2 mutations
Pristauz, G., Petru, E., Stacher, E., Geigl, J., Schwarzbraun, T., Tsybrovskyy, O., Winter, R., & Moinfar, F. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03724.x · Cited by 30
SUMO Proteases: Redox Regulation and Biological Consequences
Xu, Z., Chan, H., Lam, W. L. M., Lam, K. H., Lam, L. S. M., Ng, T. B., & Au, S. W. N. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2182 · Cited by 31
Genomic characterization of two large Alu-mediated rearrangements of the BRCA1 gene
Peixoto, A., Pinheiro, M., Massena, L., Santos, C., Pinto, P., Rocha, P., Pinto, C., & Teixeira, M. R. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.137 · Cited by 31
Common and Unique microRNAs in Multiple Carcinomas Regulate Similar Network of Pathways to Mediate Cancer Progression
Niveditha, D., Jasoria, M., Narayan, J., Majumder, S., Mukherjee, S., Chowdhury, R., & Chowdhury, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-59142-9 · Cited by 30
Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study
Prochazka, M., Hall, P. N., Granath, F. N., & Czene, K. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603404 · Cited by 30
Evolution by Phenotype: A Biomedical Perspective
Weiss, K. M., & Buchanan, A. V. (2003) · Perspectives in biology and medicine · doi:10.1353/pbm.2003.0032 · Cited by 30
Association between polymorphisms of trinucleotide repeat containing 9 gene and breast cancer risk: evidence from 62,005 subjects
Chen, M., Wu, X., Shen, W., Wei, M.-X., Li, C., Cai, B., Tao, G., & Lu, P. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1114-6 · Cited by 29
A-kinase anchor protein 12 (AKAP12) inhibits cell migration in breast cancer
Soh, R. Y. Z., Lim, J. P., Samy, R. P., Chua, P. J., & Bay, B. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.10.010 · Cited by 31
Cancer-causingBRCA2missense mutations disrupt an intracellular protein assembly mechanism to disable genome maintenance
Lee, M.-Y., Shorthouse, D., Mahen, R., Hall, B. A., & Venkitaraman, A. R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab308 · Cited by 30
Error-prone repair of stalled replication forks drives mutagenesis and loss of heterozygosity in haploinsufficient BRCA1 cells
Deshpande, M., Paniza, T., Jalloul, N., Nanjangud, G. J., Twarowski, J. M., Koren, A., Zaninović, N., Zhan, Q., Chadalavada, K., Malkova, A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.08.017 · Cited by 30
Development of APE1 enzymatic DNA repair assays: low APE1 activity is associated with increase lung cancer risk
Sevilya, Z., Leitner‐Dagan, Y., Pinchev, M., Kremer, R., Elinger, D., Lejbkowicz, F., Rennert, H. S., Freedman, L. S., Rennert, G., Paz-Elizur, T., et al. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv082 · Cited by 28
Cancer Risk Management Decision Making for BRCA+ Women
Jabaley, T., & Mawn, B. E. (2014) · Western Journal of Nursing Research · doi:10.1177/0193945913519870 · Cited by 29
Assessment of UCOE on Recombinant EPO Production and Expression Stability in Amplified Chinese Hamster Ovary Cells
Betts, Z., & Dickson, A. J. (2015) · Molecular Biotechnology · doi:10.1007/s12033-015-9877-y · Cited by 30
Infrequent mutation in the BRCA2 gene in esophageal squamous cell carcinoma.
Hu, N., Li, G., Li, W., Wang, C., Goldstein, A. M., Tang, Z., Roth, M. J., Dawsey, S. M., Huang, J. L., Wang, Q., et al. (2002) · PubMed · Cited by 29
Lower level of BRCA2 protein in heterozygous mutation carriers is correlated with an increase in DNA double strand breaks and an impaired DSB repair
Arnold, K., Kim, M., Frerk, K., Edler, L., Savelyeva, L., Schmezer, P., & Wiedemeyer, R. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.11.041 · Cited by 30
Development and Pilot Evaluation of Novel Genetic Educational Materials Designed for an Underserved Patient Population
Lubitz, R., Komaromy, M. S., Crawford, B., Beattie, M. S., Lee, R., Luce, J. A., & Ziegler, J. L. (2007) · Genetic Testing · doi:10.1089/gte.2007.0012 · Cited by 29
Low-level constitutional mosaicism of a de novoBRCA1 gene mutation
Friedman, E., Efrat, N., Soussan‐Gutman, L., Dvir, A., Kaplan, Y., Ekstein, T., Nykamp, K., Powers, M. P., Rabideau, M. M., Sorenson, J. M., et al. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.14 · Cited by 28
Familial Breast/Ovarian Cancer and BRCA1/2 Genetic Screening: The Role of Immunohistochemistry as an Additional Method in the Selection of Patients
Vaz, F., Machado, P. M., Brandão, R. D., Laranjeira, C., Eugénio, J. S., Fernandes, A., & André, S. (2007) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.7a7209.2007 · Cited by 28
Interferon-γ signaling is associated with BRCA1 loss-of-function mutations in high grade serous ovarian cancer
Cárdenas, H., Jiang, G., Pepin, J. T., Parker, J. B., Condello, S., Nephew, K. P., Nakshatri, H., Chakravarti, D., Liu, Y., & Matei, D. E. (2019) · npj Precision Oncology · doi:10.1038/s41698-019-0103-4 · Cited by 27
Novel somatic mutations in the BRCA1 gene in sporadic breast tumors
Janatová, M., Zikán, M., Dundr, P., Matouš, B., & Pohlreich, P. (2005) · Human Mutation · doi:10.1002/humu.9308 · Cited by 28
Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer
Manderson, E. N., Presneau, N., Provencher, D. M., Mes‐Masson, A., & Tonin, P. N. (2002) · Molecular Carcinogenesis · doi:10.1002/mc.10051 · Cited by 28
Basic and Preclinical Research for Personalized Medicine
Lattanzi, W., Ripoli, C., Greco, V., Barba, M., Iavarone, F., Minucci, A., Urbani, A., Grassi, C., & Parolini, O. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11050354 · Cited by 30
BRCA Mutations—The Achilles Heel of Breast, Ovarian and Other Epithelial Cancers
Loboda, A. P., Adonin, L., Zvereva, S. D., Pestov, N. B., Guschin, D. Y., Korneenko, T. V., Telegina, A. V., Kondratieva, O. K., Frolova, S. E., & Barlev, N. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054982 · Cited by 32
BRCA1-mediated repression of select X chromosome genes
Jazaeri, A. A., Chandramouli, G. V. R., Aprelikova, O. N., Nuber, U. A., Sotiriou, C. P., Liu, E. T., Ropers, H., Yee, C. J., Boyd, J. A., & Barrett, J. C. (2004) · Journal of Translational Medicine · doi:10.1186/1479-5876-2-32 · Cited by 27
Reviewing the characteristics of BRCA and PALB2-related cancers in the precision medicine era
Macedo, G. S., Alemar, B., & Ashton‐Prolla, P. (2019) · Genetics and Molecular Biology · doi:10.1590/1678-4685-gmb-2018-0104 · Cited by 28
The Melanoma and Breast Cancer Association: An Overview of their ‘Second Primary Cancers’ and the Epidemiological, Genetic and Biological correlations
Jeyakumar, A., Chua, T. C., Lam, A. K.-Y., & Gopalan, V. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102989 · Cited by 26
Cost-Effectiveness Analysis of Olaparib Maintenance Treatment for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Li, N., Zheng, H., Huang, Y., Zheng, B., Cai, H., & Liu, M. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.632818 · Cited by 26
Genomic alterations as mediators of miRNA dysregulation in ovarian cancer
Kan, C. W. S., Howell, V. M., Hahn, M. A., & Marsh, D. J. (2014) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22221 · Cited by 27
The association between polymorphisms in the leptin receptor gene and risk of breast cancer: a systematic review and pooled analysis
Wang, L., Shen, W., Xu, L., Chen, M., Gong, T., Lu, P., & Tao, G. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2228-9 · Cited by 26
Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia
Konečný, M., Milly, M., Závodná, K., Weismanova, E., Gregorova, J., Mlkva, I., Ilenčíková, D., Kausitz, J., & Bartošová, Z. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1325-x · Cited by 26
BRCA1 and BRCA2 mutations in Scotland and Northern Ireland
The Scottish/Northern Irish BRCA1/BRCA2 Consortium (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600840 · Cited by 26
Genetics of Prostate Cancer Risk
Pomerantz, M. M., & Freedman, M. L. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20222 · Cited by 26
Increased risks of third primary cancers of non-breast origin among women with bilateral breast cancer
Kwast, A. B. G., Liu, L., Roukema, J. A., Voogd, A. C., Jobsen, J. J., Coebergh, J. W. W., Soerjomataram, I., & Siesling, S. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.270 · Cited by 26
BRCA1 deficiency induces protective autophagy to mitigate stress and provides a mechanism for BRCA1 haploinsufficiency in tumorigenesis
Tang, M. K. S., Kwong, A., Tam, K., Cheung, A., Ngan, H., Xia, W., & Wong, A. S. T. (2014) · Cancer Letters · doi:10.1016/j.canlet.2013.12.026 · Cited by 25
Does folate intake decrease risk of postmenopausal breast cancer among women with a family history?
Sellers, T. A., Grabrick, D. M., Vierkant, R. A., Harnack, L., Olson, J. E., Vachon, C. M., & Cerhan, J. R. (2004) · Cancer Causes & Control · doi:10.1023/b:caco.0000019471.97208.c6 · Cited by 25
Familial breast cancer: double heterozygosity for BRCA1 and BRCA2 mutations with differing phenotypes
Smith, M., Fawcett, S., Sigalas, E., Bell, R. M., Devery, S., Andrieska, N., & Winship, I. (2007) · Familial Cancer · doi:10.1007/s10689-007-9154-8 · Cited by 26
Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans
Burk, A., Scally, M., Amrine‐Madsen, H., Stanhope, M. J., & Springer, M. S. (2006) · Mammalian Genome · doi:10.1007/s00335-005-0067-2 · Cited by 26
Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors
Berns, E. M. J. J., Dirkzwager-Kiel, M. M., Kuenen‐Boumeester, V., Timmermans, M. A. M., Verhoog, L. C., van den Ouweland, A. M. W., Meijers-Heijboer, H. E. J., Klijn, J. G. M., & van der Kwast, T. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023347409599 · Cited by 25
S-Adenosylmethionine: A Multifaceted Regulator in Cancer Pathogenesis and Therapy
Fernández‐Ramos, D., Lopitz‐Otsoa, F., Lu, S. C.-L., & Mato, J. M. (2025) · Cancers · doi:10.3390/cancers17030535 · Cited by 28
A Dietary Intervention to Lower Serum Levels of IGF-I in BRCA Mutation Carriers
Pasanisi, P., Bruno, E., Venturelli, E., Morelli, D., Oliverio, A., Baldassari, I., Rovera, F. A., Iula, G., Taborelli, M., Peissel, B., et al. (2018) · Cancers · doi:10.3390/cancers10090309 · Cited by 24
HRness in Breast and Ovarian Cancers
Santos, E. S. D., Lallemand, F., Petitalot, A., Caputo, S. M., & Rouleau, É. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21113850 · Cited by 24
Deletion mapping of chromosome 13q in head and neck squamous cell carcinoma in Indian patients: correlation with prognosis of the tumour
Sabbir, M. G., Roy, A. K., Mandal, S., Dam, A., Roychoudhury, S., & Panda, C. K. (2006) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2006.00467.x · Cited by 24
Heritable Susceptibility Factors for the Development of Cancer
Au, W. W. (2006) · Journal of Radiation Research · doi:10.1269/jrr.47.b13 · Cited by 24
BRCA1 and BRCA2 mutations have no major role in predisposition to prostate cancer in Finland
Ikonen, T., Matikainen, M., Syrjäkoski, K., Mononen, N., Koivisto, P., Rökman, A., Seppälä, E., Kallioniemi, O., Tammela, T., & Schleutker, J. (2003) · Journal of Medical Genetics · doi:10.1136/jmg.40.8.e98 · Cited by 31
Breast cancer as a mitochondrial disorder (Review)
Czarnecka (2009) · Oncology Reports · doi:10.3892/or_00000293 · Cited by 24
A Physical Mechanism and Global Quantification of Breast Cancer
Yu, C., & Wang, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0157422 · Cited by 23
Proteomic analysis of a preneoplastic phenotype in ovarian surface epithelial cells derived from prophylactic oophorectomies
He, Q., Zhou, Y., Wong, E., Ehlen, T. G., Auersperg, N., Chiu, J., & Wong, A. S. T. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.04.002 · Cited by 25
Nuclear matrix proteins as biomarkers for breast cancer
Lüftner, D., & Possinger, K. (2002) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2.1.23 · Cited by 24
Relationship between Genetic Polymorphisms in MTHFR (C677T, A1298C and their Haplotypes) and the Incidence Of Breast Cancer among Jordanian Females - Case-Control Study
Awwad, N., Yousef, A., Abuhaliema, A., Abdalla, I., & Yousef, M. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.12.5007 · Cited by 23
Glucocorticoid receptor expression is associated with inferior overall survival independent of BRCA mutation status in ovarian cancer
Veneris, J. T., Huang, L., Churpek, J. E., Conzen, S. D., & Fleming, G. F. (2019) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-2018-000101 · Cited by 23
19F NMR Spectroscopy Tagging and Paramagnetic Relaxation Enhancement‐Based Conformation Analysis of Intrinsically Disordered Protein Complexes
Somlyay, M., Ledolter, K., Kitzler, M., Sandford, G., Cobb, S. L., & Konrat, R. (2019) · ChemBioChem · doi:10.1002/cbic.201900453 · Cited by 23
E3 ligase RFWD3 is a novel modulator of stalled fork stability in BRCA2-deficient cells
Duan, H., Mansour, S., Reed, R., Gillis, M. K., Parent, B., Liu, B., Sztupinszki, Z. M., Birkbak, N. J., Szállási, Z., Elia, A. E. H., et al. (2020) · The Journal of Cell Biology · doi:10.1083/jcb.201908192 · Cited by 22
Human BRCA pathogenic variants were originated during recent human history
Li, J., Zhao, B., Huang, T., Qin, Z., & Wang, S. M. (2022) · Life Science Alliance · doi:10.26508/lsa.202101263 · Cited by 23
Hormonal Heterogeneity of Endometrial Cancer
Gründker, C., Günthert, A. R., & Emons, G. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-78818-0_11 · Cited by 23
Evaluating Tumor Evolution via Genomic Profiling of Individual Tumor Spheroids in a Malignant Ascites
Kim, S., Kim, S., Kim, J., Kim, B., Kim, S. I., Kim, M. A., Kwon, S., & Song, Y. S. (2018) · Scientific Reports · doi:10.1038/s41598-018-31097-y · Cited by 23
Biosensors for Rapid Detection of Breast Cancer Biomarkers
Pereira, A., Sales, M., & Rodrigues, L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815743-5.00003-2 · Cited by 25
Genetic and molecular biology of breast cancer among Iranian patients
Moghbeli, M. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-1968-2 · Cited by 25
Anticipation in hereditary breast cancer
Dagan, E., & Gershoni‐Baruch, R. (2002) · Clinical Genetics · doi:10.1034/j.1399-0004.2002.620207.x · Cited by 23

Authors: Welcsh, P. L.
Affiliations: University of Washington (US)
Corresponding author: Welcsh, P. L.
Venue: Human Molecular Genetics
Publisher: Oxford University Press (OUP)
Published: 2001-04-01
Volume: 10
Issue: 7
Pages: 705-713
ISSN: 0964-6906 (ISSN-L)
1460-2083
DOI: 10.1093/hmg/10.7.705
OpenAlex: W2124371549
Cited by: 648
References: 93
Citations by year: 2026: 11 · 2025: 16 · 2024: 25 · 2023: 19 · 2022: 19 · 2021: 26 · 2020: 27 · 2019: 33 · 2018: 30 · 2017: 36 · 2016: 34 · 2015: 31 · 2014: 29 · 2013: 25 · 2012: 17
FWCI: 4.10
Type: journal article
Language: en
Open access: closed
Locations: Human Molecular Genetics (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ca027632-22)
National Cancer Institute (CA27632)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Keywords: BRCA1, BRCA2, hereditary breast cancer, hereditary ovarian cancer, germline mutations, somatic mutations, DNA repair, transcriptional regulation, repetitive elements, chromosomal instability, genome rearrangement, carcinogenesis, tumor suppressor
MeSH terms: Breast Neoplasms, Cell Division, Chromosomes, Estrogens, Female, Humans, Models, Biological, Mutation, Neoplasm Proteins, Ovarian Neoplasms, Repetitive Sequences, Nucleic Acid, Transcription Factors, Gene Deletion, Genes, BRCA1, Genetic Predisposition to Disease, BRCA2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

BRCA1 and BRCA2 and the genetics of breast and ovarian cancer

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks